← Back to Search

Advanced Rehabilitation Technology for Neurological Disorders

N/A
Recruiting
Led By Brett Schoen, MD
Research Sponsored by Rehabilitation Hospital of Overland Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights

Study Summary

This trial compares using robotic devices & advanced tech with traditional rehab to improve outcomes for people w/ neurological diagnoses and save money.

Who is the study for?
This trial is for adults over 18 with neurological disorders who are in inpatient rehab and can stay at least 7 days. They must be able to communicate, follow commands, fit into a device, and tolerate certain positions. Excluded are those with conditions limiting study benefits or involved in another study.Check my eligibility
What is being tested?
The study tests if using robotic devices like Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics during rehab gives similar or better results than standard therapy alone. It's randomized: some get technology-assisted therapy; others don't.See study design
What are the potential side effects?
Potential side effects may include discomfort from fitting into the devices or fatigue due to increased intensity of rehabilitation sessions. There might also be risks specific to each device used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neuro-QOL
Secondary outcome measures
10 Meter Walk Test
Areas of pain
Cost of caregiver burden
+13 more
Other outcome measures
Goal attainment scale (GAS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Inpatient Rehabilitation with ARTExperimental Treatment1 Intervention
Inpatient rehabilitation with advanced rehabilitation technology
Group II: Inpatient Rehabilitation without ARTActive Control1 Intervention
Inpatient rehabilitation without advanced rehabilitation technology

Find a Location

Who is running the clinical trial?

Rehabilitation Hospital of Overland ParkLead Sponsor
Discovery StatisticsUNKNOWN
Brett Schoen, MDPrincipal InvestigatorRehabilitation Hospital of Overland Park

Media Library

Inpatient Rehabilitation with ART Clinical Trial Eligibility Overview. Trial Name: NCT05652946 — N/A
Neurological Disorders Research Study Groups: Inpatient Rehabilitation with ART, Inpatient Rehabilitation without ART
Neurological Disorders Clinical Trial 2023: Inpatient Rehabilitation with ART Highlights & Side Effects. Trial Name: NCT05652946 — N/A
Inpatient Rehabilitation with ART 2023 Treatment Timeline for Medical Study. Trial Name: NCT05652946 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical experiment actively seeking out participants?

"Affirmative. The info posted on clinicaltrials.gov indicates that this research is still open for enrollment, with an original post date of October 17th 2022 and a most recent update from December 7th 2022. This study needs 200 participants to be recruited through 1 medical centre."

Answered by AI

What is the cohort size for this experimental research?

"Affirmative. Per the information on clinicaltrials.gov, this research program is actively looking for candidates to participate in their study. It was initially posted on October 17th 2022 and last updated December 7th 2022; a total of 200 participants are needed from one centre."

Answered by AI
~42 spots leftby Oct 2024